Literature DB >> 10477116

Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 mediated transport system.

T Fujita1, T Kishida, N Okada, V Ganapathy, F H Leibach, A Yamamoto.   

Abstract

High-affinity type H+/peptide cotransporter PEPT2 is preferentially expressed in the kidney, and is responsible for reabsorption of di- and tripeptides in epithelial tubules. Interestingly, PEPT2 has been recently cloned from rat brain. However, there is very little information available on the peptide transporter activity in the brain. In the present study, we investigated the interaction of kyotorphin (L-tyrosyl-L-arginine) with the peptide transporter using synaptosomes prepared from rat cerebellum. The activity of the peptide transporter was assessed by measuring the uptake of radiolabeled glycyl-sarcosine (Gly-Sar), which is a prototypical substrate for the peptide transporter, in the presence of H+-gradient. Kyotorphin competitively inhibited the uptake of Gly-Sar with an inhibitory constant (Ki) of 30 +/- 4 microM in rat cerebellum synaptosomes. This uptake property is very close to that of PEPT2. Carnosine (beta-alanyl-L-histidine) also inhibited the uptake of Gly-Sar, on the other hand, TRH did not interact with the peptide transporter. RT-PCR using specific primers revealed that PEPT2 mRNA exists in cerebellum in rat. Taken collectively, these results indicate that the functional peptide transport system in rat cerebellum might be the high affinity transporter PEPT2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477116     DOI: 10.1016/s0304-3940(99)00540-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  PEPT2-mediated uptake of neuropeptides in rat choroid plexus.

Authors:  N S Teuscher; R F Keep; D E Smith
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 2.  Transport systems for opioid peptides in mammalian tissues.

Authors:  Vadivel Ganapathy; Seiji Miyauchi
Journal:  AAPS J       Date:  2005-12-29       Impact factor: 4.009

Review 3.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat.

Authors:  Yongjun Hu; Yehua Xie; Richard F Keep; David E Smith
Journal:  J Neurochem       Date:  2014-03-20       Impact factor: 5.372

5.  Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice.

Authors:  Huidi Jiang; Yongjun Hu; Richard F Keep; David E Smith
Journal:  J Neurochem       Date:  2009-04-04       Impact factor: 5.372

Review 6.  Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives.

Authors:  Juliana Perazzo; Miguel A R B Castanho; Sónia Sá Santos
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.